Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial
British Journal of Anaesthesia · 2023-05 · 130 (5) · 519-527
DOI: 10.1016/j.bja.2023.02.004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2023-05. Verfasst von Matthieu Legrand und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; INI-CRCT Network, Nancy, France. Electronic addres…. Hauptthemen laut MEDLINE: Hypotension, Acute Kidney Injury. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Intraoperative hypotension is associated with postoperative complications. The use of vasopressors is often required to correct hypotension but the best vasopressor is unknown. METHODS: A multicentre, cluster-randomised, crossover, feasibility and pilot trial was conducted across five hospitals in California. Phenylephrine (PE) vs norepinephrine (NE) infusion as the first-line vasopressor in patients under general anaesthesia alternated monthly at each hospital for 6 months. The primary endpoint was first-line vasopressor administration compliance of 80% or higher. Secondary endpoints were acute kidney injury (AKI), 30-day mortality, myocardial injury after noncardiac surgery (MINS), hospital length of stay, and rehospitalisation within 30 days. RESULTS: A total of 3626 patients were enrolled over 6 months; 1809 patients were randomised in the NE group, 1817 in the PE group. Overall, 88.2% received the assigned first-line vasopressor. No drug infiltrations requiring treatment were reported in either group. Patients were median 63 yr old, 50% female, and 58% white. Randomisation in the NE group vs PE group did not reduce readmission within 30 days (adjusted odds ratio=0.92; 95% confidence interval, 0.6-1.39), 30-day mortality (1.01; 0.48-2.09), AKI (1.1; 0.92-1.31), or MINS (1.63; 0.84-3.16). CONCLUSIONS: A large and diverse population undergoing major surgery under general anaesthesia was successfully enrolled and randomised to receive NE or PE infusion. This pilot and feasibility trial was not powered for adverse postoperative outcomes and a follow-up multicentre effectiveness trial is planned. CLINICAL TRIAL REGISTRATION: NCT04789330 (ClinicalTrials.gov).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; INI-CRCT Network, Nancy, France. Electronic address: Matthieu.Legrand@ucsf.edu.
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; Department of Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; School of Medicine, University of California, San Francisco, CA, USA.
- Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.
- Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Zitieren
APA
Legrand, M., Kothari, R., Fong, N., Palaniappa, N., Boldt, D., Chen, L. L., Kurien, P., Gabel, E., Sturgess-DaPrato, J., Harhay, M. O., Pirracchio, R., Bokoch, M. P., & VEGA-1 trial investigators (2023). Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial. British Journal of Anaesthesia, 130(5), 519-527. https://doi.org/10.1016/j.bja.2023.02.004
Vancouver
Legrand M, Kothari R, Fong N, Palaniappa N, Boldt D, Chen LL, et al. Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial. British Journal of Anaesthesia. 2023;130(5):519-527. doi:10.1016/j.bja.2023.02.004
BibTeX
@article{Legrand2023,
author = {Legrand, Matthieu and Kothari, Rishi and Fong, Nicholas and Palaniappa, Nandini and Boldt, David and Chen, Lee-Lynn and Kurien, Philip and Gabel, Eilon and Sturgess-DaPrato, Jillene and Harhay, Michael O and Pirracchio, Romain and Bokoch, Michael P and VEGA-1 trial investigators, VEGA-1 trial investigators},
title = {Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial},
journal = {British Journal of Anaesthesia},
year = {2023},
volume = {130},
number = {5},
pages = {519--527},
doi = {10.1016/j.bja.2023.02.004}
}
EUVIMED